Clinical and Basic Investigations Into Congenital Disorders of Glycosylation | MicrobiomeTrials← Back to trialsNCT04199000
Clinical and Basic Investigations Into Congenital Disorders of Glycosylation
RecruitingOBSERVATIONAL
Trial Details
Start: 2019-10-08Est. Completion: 2030-07-31
Enrollment target: 500 participants Locations- Rady Children's Hospital, San Diego, California, United States
- Children's Hospital of Colorado, Aurora, Colorado, United States
- Mayo Clinic Florida, Jacksonville, Florida, United States
- Tulane University School of Medicine, New Orleans, Louisiana, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
- University of Minnesota, Minneapolis, Minnesota, United States
- Mayo Clinic in Rochester, Rochester, Minnesota, United States
- Icahn School of Medicine at Mount Sinai, New York, New York, United States
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
- Baylor College of Medicine, Houston, Texas, United States
- Seattle Children's Hospital, Seattle, Washington, United States
Other microbiome trials you might be interested in
Pmm2-CDGPhosphomannomutase 2 Deficiency
The goal of this clinical trial is to provide continued access to GLM101 to treat PMM2-CDG in people who have previously…
Minneapolis, United StatesCompleted Sep 2029
LGMD2I
BBP-418 is being developed for the treatment of patients with Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I). This is a…
Richmond, United StatesEst. completion Nov 1, 2026